Evidence map›Paper›PMID 34473170›Full record

ArticleNanoscale2021

Surface enhanced Raman scattering of extracellular vesicles for cancer diagnostics despite isolation dependent lipoprotein contamination.

Hanna J Koster, Tatu Rojalin, Alyssa Powell, Dina Pham, Rachel R Mizenko, Andrew C Birkeland, Randy P Carney

Open access · hybridAbstract read
In one paragraph

Article in Nanoscale, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Extracellular vesicles isolation: a focus on magnetic beads-assisted platforms.Frontiers in bioengineering and biotechnology · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hanna J KosterDepartment of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA. rcarney@ucdavis.edu.ORCID http://orcid.org/0000-0001-7497-9993
Tatu RojalinDepartment of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA. rcarney@ucdavis.edu.
Alyssa PowellDepartment of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA. rcarney@ucdavis.edu.
Dina PhamDepartment of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA. rcarney@ucdavis.edu.
Rachel R MizenkoDepartment of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA. rcarney@ucdavis.edu.
Andrew C BirkelandDepartment of Otolaryngology - Head and Neck Surgery, University of California, Davis, Sacramento, CA 95817, USA.
Randy P CarneyDepartment of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA. rcarney@ucdavis.edu.ORCID http://orcid.org/0000-0001-8193-1664
University of California, Davis · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Gina M Dayton · 2002 to 2026
$84.9M
UC Davis Paul Calabresi K12 Clinical Oncology Research Career Development ProgramK12CA138464 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BIRKELAND, ANDREW CHARLES, LARA, PRIMO N. · 2011 to 2025
$11.4M
SERS diagnostics platform for liquid bioapsy analysis of tumor-associated exosomesR01CA241666 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CARNEY, RANDY · 2020 to 2024
$2.5M
NCI NIH HHS K12 CA138464NCI NIH HHS P30 CA093373NCI NIH HHS R01 CA241666
6 · The paper itself

Abstract

Given the emerging diagnostic utility of extracellular vesicles (EVs), it is important to account for non-EV contaminants. Lipoprotein present in EV-enriched isolates may inflate particle counts and decrease sensitivity to biomarkers of interest, skewing chemical analyses and perpetuating downstream issues in labeling or functional analysis. Using label free surface enhanced Raman scattering (SERS), we confirm that three common EV isolation methods (differential ultracentrifugation, density gradient ultracentrifugation, and size exclusion chromatography) yield variable lipoprotein content. We demonstrate that a dual-isolation method is necessary to isolate EVs from the major classes of lipoprotein. However, combining SERS analysis with machine learning assisted classification, we show that the disease state is the main driver of distinction between EV samples, and largely unaffected by choice of isolation. Ultimately, this study describes a convenient SERS assay to retain accurate diagnostic information from clinical samples by overcoming differences in lipoprotein contamination according to isolation method.

Indexed as

Extracellular VesiclesNeoplasmsChromatography, GelHumansLipoproteinsSpectrum Analysis, RamanUltracentrifugationLipoproteins

Identifiers

PMID34473170
PMCPMC8447870
OpenAlexW3193641608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.